Health News

CARROLLTON, Ga.--(BUSINESS WIRE)--Tanner Health and Mercer University School of Medicine celebrated the opening of their Carrollton clinical campus and simulation lab....

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that on July 15, 2026, it granted options to purchase an aggregate of 160,000 shares of DiaMedica’s common stock to a newly hired non-executive employee whose employment commenced in July 2026. The stock options were a material inducement to the employee’s...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will conduct a search for her permanent successor, with Yemi Okupe, CFO of Hims & Hers, assuming the responsibilities of...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 118,586 shares of its common stock to eleven newly hired employees, consisting of inducement stock options to purchase an aggregate of 33,987 shares of common stock and inducement restricted stock units, covering an aggregate of 84,599 shares of its common stock. The awards are subject to all terms and conditions and other provi...

BOSTON--(BUSINESS WIRE)--In a significant move to advance the treatment of patients with inflammatory breast cancer (IBC), Dana-Farber Cancer Institute, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), and the Inflammatory Breast Cancer Research Foundation today announced a collaborative research initiative uniting two comprehensive IBC clinics. The collaborative research project will include patients from both Dana-Fa...

PALOS PARK, Ill.--(BUSINESS WIRE)--Heart Care Centers of Illinois (“HCCI”), located at 13011 S. 104th Avenue, Suite 100, Palos Park, IL 60464, is issuing this notice about a data security incident that may have resulted in unauthorized access to certain personal and protected health information of its employees and patients. Please know that HCCI moved swiftly to investigate and remediate the incident. Information about the incident, HCCI’s response, and the steps you may take to help protect y...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Data to Be Highlighted in Four Rapid Oral Presentations at ESMO 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers...

GAINESVILLE, Fla.--(BUSINESS WIRE)--The UF Health lung transplant program has again been recognized by the Scientific Registry of Transplant Recipients, or SRTR, for outstanding patient outcomes, reinforcing its reputation as a premier choice for patients seeking lung transplantation. The latest SRTR rankings show the program continues to meet or exceed national benchmarks across key measures, including short- and long-term post-transplant survival, waitlist survival and timely access to transp...

DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or “ASPI”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, and ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or “NDRA”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced that RedChip Companies will host an investor webi...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three abstracts from investigator-sponsored trials evaluating botensilimab and balstilimab (BOT+BAL) have been accepted for poster presentation at the European Society for Medical Oncology (ESMO) Congress 2026, taking place October 23-27, 2026, in Madrid, Spain. The studies span neoadjuvant colorectal cancer, refractory metastatic colorectal cancer and advanced sarcoma, re...